Variables | EFS | LF | ||||
---|---|---|---|---|---|---|
5-year CI | HR (95% CI) | p | 5-year CI | HR (95% CI) | p | |
All patients | 62.1% | - | - | 6.9% | - | - |
Age group | ||||||
≤ 15 years | 68.0% | 1.00 | 4.6% | 1.00 | ||
> 15 years | 47.6% | 2.00 (0.91–4.41) | 0.087 | 13.8% | 3.11 (0.44–22.1) | 0.257 |
Sex | ||||||
Male | 64.0% | 1.00 | 9.1% | 1.00 | ||
Female | 58.6% | 1.30 (0.60–2.83) | 0.513 | 4.8% | 0.58 (0.06–5.53) | 0.575 |
Risk group | ||||||
Low | 73.7% | 1.00 | 5.6% | 1.00 | ||
High | 48.2% | 1.74 (0.80–3.80) | 0.163 | 8.3% | 1.33 (0.19–9.41) | 0.779 |
Tumor size | ||||||
≤ 8 cm | 61.1% | 1.00 | -- | -- | -- | |
> 8 cm | 58.1% | 1.07 (0.41–2.76) | 0.892 | -- | -- | -- |
Necrosis Index | ||||||
≤ 95% | 60.7% | 1.38 (0.54–3.57) | 0.503 | 5.6% | 0.41 (0.04–4.52) | 0.466 |
> 95% | 71.3% | 1.00 | 10.5% | 1.00 | ||
LDH | ||||||
≥ 1.5 x ULN | 51.3% | 1.11 (0.44–2.77) | 0.832 | 15.4% | 6.04 (0.55–66.7) | 0.142 |
< 1.5 x ULN | 63.1% | 1.00 | 2.4% | 1.00 | ||
Pelvic location | ||||||
Yes | 41.1% | 1.47 (0.55–3.90) | 0.440 | -- | -- | -- |
No | 66.7% | 1.00 | -- | -- | -- | |
Radiation dose | - | 0.99 (0.98–1.01) | 0.560 | - | 0.98 (0.86–1.12) | 0.796 |